α2-Adrenoceptor blockade prevents cardiac glycoside-evoked neurotransmitter release from sympathetic nerves in dog saphenous vein
Open Access
- 1 September 1987
- journal article
- research article
- Published by Wiley in British Journal of Pharmacology
- Vol. 92 (1) , 213-220
- https://doi.org/10.1111/j.1476-5381.1987.tb11314.x
Abstract
1 The effect of α-adrenoceptor antagonists upon neurotransmitter release evoked by cardiac glycosides from sympathetic nerve terminals has been investigated in dog saphenous vein. 2 In rings of saphenous vein preloaded with [3H]-noradrenaline, acetylstrophanthidin (ACS) caused a concentration-dependent efflux of 3H (EC50 ca. 4.4 μm) that was attenuated by phentolamine and yohimbine but not by prazosin. 3 In helical strips of saphenous vein superfused with ACS at EC50 the efflux of 3H-compounds in general, and of [3H]-noradrenaline in particular, occurred after a short delay and increased with time to a maximum reached at 75 min. Phentolamine and phenoxybenzamine, but not prazosin reduced the efflux of [3H]-noradrenaline and of total 3H-compounds throughout the time-course of the ACS-evoked effect. 4 In helical strips of saphenous vein the glycoside ouabain also caused an increase in [3H]-noradrenaline and in total 3H-efflux that was attenuated by phentolamine. 5 By contrast with the above, in bovine adrenal medullary chromaffin cells, which appear to have no functional α-adrenoceptors, ACS caused a small, but significant increase in 3H-efflux which was not prevented by phentolamine. 6 Phentolamine, at concentrations that attenuate markedly the ouabain-or ACS-evoked increase in 3H-efflux from dog saphenous vein, did not cause significant inhibition of cocaine-sensitive [3H]-noradrenaline uptake nor did it reduce the extent of the 3H-efflux evoked either by tyramine or by reduced extracellular Na+. These findings imply that phentolamine does not affect ACS-evoked neurotransmitter release by an action on the catecholamine uptake mechanism. 7 It is concluded that the cardiac glycoside-evoked increase in neurotransmitter release from noradrenergic nerve terminals of dog saphenous vein is modulated by a mechanism that involves an α2-adrenoceptor.This publication has 18 references indexed in Scilit:
- The role of co-transported sodium in the effect of indirectly acting sympathomimetic aminesNaunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie, 1986
- Unsuitability of the 86Rb+ uptake method for estimation of (Na+ + K+)-ATPase activity in innervated tissuesBiochimica et Biophysica Acta (BBA) - Biomembranes, 1986
- REVIEW CARDIAC GLYCOSIDES AND AUTONOMIC NEUROTRANSMISSIONJournal of Autonomic Pharmacology, 1983
- Does Na,K-ATPase play a role in the regulation of neurotransmitter release by prejunctional α-adrenoceptors?Biochemical Pharmacology, 1981
- The effects of acetylstrophanthidin and ouabain on the sympathetic adrenergic neuroeffector junction in canine vascular smooth muscle.Circulation Research, 1980
- Regulation of noradrenaline release by presynaptic receptor systemsPublished by Springer Nature ,1977
- Influence of drugs with affinity for α-adrenoceptors on noradrenaline release by potassium, tyramine and dimethylphenylpiperaziniumEuropean Journal of Pharmacology, 1974
- Mechanism of efflux of noradrenaline from adrenergic nerves in rabbit atriaBritish Journal of Pharmacology, 1973
- Evidence for sodium dependent outward transport of the 3H-norepinephrine mobilized by calcium at the adrenergic synapse. Inhibition of transport by desipramineLife Sciences, 1972
- Abbauversuche an Strophanthidin. Glykoside und AglykoneHelvetica Chimica Acta, 1947